| 1 | 
                
                    IL17A
                
             💬
 | [6]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Secukinumab 
                
                    Secukinumab
                
             💬
 | 
                
                    Secukinumab
                
             | [8]  13 13, 37, 41, 46, 107, 160, 269, 271 💬
 | 
| 2 | 
                
                    IL17A
                
             💬
 | [6]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Ixekizumab 
                
                    Ixekizumab
                
             💬
 | 
                
                    Ixekizumab
                
             | [8]  36 36, 37, 46, 107, 160, 162, 269, 271 💬
 | 
| 3 | 
                
                    IL17A
                
             💬
 | [6]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Tibulizumab 
                
                    Tibulizumab
                
             💬
 | 
                
                    Tibulizumab
                
             | [1]  53 53 💬
 | 
| 4 | 
                
                    IL17A
                
             💬
 | [6]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Bimekizumab 
                
                    Bimekizumab
                
             💬
 | 
                
                    Bimekizumab
                
             | [3]  46 46, 97, 271 💬
 |